Oncotelic Therapeutics Inc · OTC:OTLC

Oncotelic Therapeutics — Mateon Therapeutics — Investor Presentation (December 2019)

18 slides from Oncotelic Therapeutics's investor presentation, Dec 6, 2019

  1. Slide 1: EdgePoint: AI Blockchain Fabric for Pharmaceutical Manufacturing

    EdgePoint 4) Al BLOCKCHAIN FABRIC FOR PHARMACEUTICAL MANUFACTURING A DIVISION OF MATEON (MATN) ADDRESSING THE HITHERTO UNSOLVABLE PROBLEM OF A 1 TRILLION DOLLAR INDUSTRY DEC 1, 2019 2019 This Material Contains Mateon Confidential information

  2. Slide 2: Forward-Looking Statements

    FORWARD-LOOKING STATEMENTS * This document contains “forward-looking statements” that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in t

  3. Slide 3: The EdgePoint Team

    THE EDGEPOINT TEAM Saran Saund CSR MARVELL CYBERCASH Silicon Valley team of successful entrepreneurs XEROX PARC Customer engagements include with leading retail and transportation players, inet and go-to-market with IBM General Manager / Al Division World-class team and academia in Deep Learning Fun

  4. Slide 4: The Problem: Data Integrity in Drug Manufacturing

    The Problem DATA INTEGRITY IS THE SINGLE MOST IMPORTANT PROBLEM IN DRUG MANUFACTURING Number of warning letters to drugmakers * Data manipulation and data integrity remain an 80 unsolvable human problem of a 1 Trillion dollar 70 pharmaceutical industry * The recent spike in warnings is the result of

  5. Slide 5: Data Manipulation: The Most Insidious Form of Data Integrity Problem

    The Problem DATA MANIPULATION- THE MOST INSIDIOUS FORM OF DATA INTEGRITY PROBLEM DATA INTEGRITY PROBLEMS * Data from 5.5 years of FDA Number of violationissued Data Integrity Violations ™ Data Manipulation Violations inspection records, from 2014 to the present, revealed endemic data integrity issue

  6. Slide 6: Primary Issues Responsible for Data Integrity Failure

    The Problem PRIMARY ISSUES RESPONSIBLE FOR DATA INTEGRITY FAILURE Ignorance and 28 tc Company culture: Human error: Inefficient systems: disengagement: * Pharma biotech employees *A company culture where The human element, of *needlessly complex data can often fail to employees feel unable to course

  7. Slide 7: EdgePoint AI/Blockchain Fabric as the Solution

    EDGEPOINT Al/BLOCKCHAIN FABRIC AS THE SOLUTION Leveraging on PointR Cluster Computing and Vision Technology Easy to implement global control and data integration system for CDMO EdgePoint Vision Fabric for real time Al Vision control flow EdgePoint Smart Protocol for real time immutable data flow Hi

  8. Slide 8: Complete AI Vision Blockchain Product

    COMPLETE Al VISION BLOCKCHAIN PRODUCT INTEGRATED HARDWARE SOFTWARE APPLIANCE FOR EASY ONBOARDING MANUFACTURING PLANT BRICK 2.0 4 Reduced Size hub of Al accelerator cluster for efficient localized cluster compute » 30W fan-less compute hub of Al accelerator cluster connects wirelessly to provide an A

  9. Slide 9: Machine Vision and Blockchain: Track & Integrate Men/Materials/Data Flows

    MACHINE VISION AND BLOCKCHAIN: TRACK & INTEGRATING MEN/MATERIALS/DATA FLOWS 1. Automatically track real-time workflow of Z : . oo | ‘. (i ae mi > @ ih = a od 4 materials, personnel, equipment and = f ; Ak products to achieve instant traceability and , — - . compliance 2. Potential to identify issues

  10. Slide 10: How Does It Work?

    Da Blockchain Hyper- ledger enter HOW DOES IT WORK? MFG Plant y é Contains immutable transactions generated by Vision Fabric at the plant S= LC ] Step 5 Meta data inserted in local Data Collection: 100K’s of Spotlight Cameras connect to federated Blockchain images for 10K’s of labels rs ] PointR Cub

  11. Slide 11: EdgePoint Manufacturing Workflow Augmented with AI Vision, NLP and Blockchain

    EDGEPOINT MANUFACTURING WORKFLOW AUGMENTED WITH Al VISION, NLP AND BLOCKCHAIN Smart Protocol/ Sean Nanosizing Process/SOP 8 Man Flow! 1so-5 1SO-5 Vision Material Raw Nonsterile Flow/ Vision Materials Liquid Data Flow/ . Particle Sensors Wee Size QA Alert/ Al Out of Out of Learning specs specs Block

  12. Slide 12: Examples of PointR Technologies

    EXAMPLES OF POINTR TECHNOLOGIES 12

  13. Slide 13: Go-to-Market Partnership with IBM

    GO-TO-MARKET PARTNERSHIP WITH IBM LAUNCHED AT SUPERCOMPUTING 2018 * PointR established a worldwide partnership with IBM and been active in retail and transportation sectors * PointR as part of Mateon is working together with IBM Global Services to provide solutions to the Life Sciences vertical amon

  14. Slide 14: The Power Performance Disruption

    THE POWER PERFORMANCE DISRUPTION PointR BRICK 1.0 Can be used in any office environment Specs — BRICK 1.0 7.8 fps Inference 100 Watts Peak 9 Teraflops @16-bit PCle Fabric @10Gbps DMA Better than AC922 with V100 6.77 fps Inference 2200W Power 1/20" power IBM AC922 $53,000 price * 6x NV100 + 2x PPC9 1

  15. Slide 15: The Power Performance Disruption

    THE POWER PERFORMANCE DISRUPTION Specs 6 Al Accelerators Cluster Processing 100 Watts Peak 9 Teraflops @16-bit PCle Fabric @10Gbps DMA Equals 11x Xeon 2790v4 CPU Dell r730 servers 1/100** power 1/20" price That's 11 Dell servers 15

  16. Slide 16: EdgePoint: Single Platform AI-Based Solution to Data Integrity Problems

    EDGEPOINT: SINGLE PLATFORM AI-BASED SOLUTION TO DATA INTEGRITY PROBLEMS TRUST Real time integration of control flow and data flow into immutable blockchain which is open to all stakeholders including FDA FLEXIBLE Global control and data integration system with or without middleware HUMAN Connecting

  17. Slide 17: Call to Action: Rapid Onboarding POCs with IBM

    CALL 1 TO ACTION: RAPID ONBOARDING POCS WITH IBM Silver Gold Plati 1 week 6 week 16 week Installation Rapid Prototype Deployment Infra, solution, Onsite Infrastructure Infrastructure & integration, & Engineering Engineering Solution Engineering business logic engineering Quickstart Install and 1-Use

  18. Slide 18: Thank You

    Thank You Vuong Trieu/ vtrieu@oncotelic.com Saran Saund/ saran@pointrdata.com 18

Mateon Therapeutics — Investor Presentation (December 2019) on 6ix